Journey Medical (DERM) Change in Receivables (2020 - 2026)

Journey Medical's Change in Receivables history runs 7 years deep, the most recent figure standing at -$4.8 million for Q1 2026.

• Quarterly Change in Receivables fell 159.59% year-over-year to -$4.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.6 million (down 26.2% YoY) and the FY2025 annual result came in at $19.3 million, up 532.2% from the prior year.
• Change in Receivables was -$4.8 million for Q1 2026 at Journey Medical, down from $11.8 million in the prior quarter.
• Across five years, Change in Receivables topped out at $11.8 million in Q4 2025 and bottomed at -$10.4 million in Q2 2023.
• A 5-year average of $172588.2 and a median of -$83000.0 in 2022 frame the typical range for Change in Receivables.
• Peak annual rise in Change in Receivables reached 14170.59% in 2023, while the deepest fall reached 10538.55% in 2023.
• Journey Medical's Change in Receivables stood at -$51000.0 in 2022, then jumped by 14170.59% to $7.2 million in 2023, then tumbled by 110.41% to -$747000.0 in 2024, then jumped by 1674.16% to $11.8 million in 2025, then tumbled by 140.49% to -$4.8 million in 2026.
• Business Quant data shows DERM's Change in Receivables at -$4.8 million in Q1 2026, $11.8 million in Q4 2025, and $2.4 million in Q3 2025.